RUA Life Sciences plc (RUA.L)

10.75 +0.50 (+4.88%) At close: 06:19PM BST

RUA Life Sciences plc

2 Drummond Crescent
Irvine
KA11 5AN
United Kingdom
44 12 9431 7073
https://rualifesciences.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 48

Key executives

Name	Title	Pay	Exercised	Year born
Mr. William Donald Brown	Executive Chairman	266.98k	N/A	1963
Mr. Lachlan Arthur Smith	CFO & Director	139k	N/A	1980
Mr. John McKenna	Director of Clinical Marketing & Executive Director	73.78k	N/A	1953
Kathryn Mary Full FCCA	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturing, assembly, packing and services to the medical device. The Vascular segment develops bore polymer sealed grafts and soft tissue patches. The Structural Heart segment manufactures synthetic heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Ayrshire, the United Kingdom.

Corporate governance

RUA Life Sciences plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.